Nexalin Technology, Inc. (NXLIW)
USD 0.17
(20.14%)
USD 0.17
(20.14%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 85.06 Thousand USD | -235.98% |
| 2022 | 958.14 Thousand USD | 681.37% |
| 2021 | 122.62 Thousand USD | -42.67% |
| 2020 | 213.87 Thousand USD | 2075.39% |
| 2019 | -10.82 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -287.88 Thousand USD | -12.06% |
| 2024 Q1 | -256.9 Thousand USD | 36.82% |
| 2023 Q4 | -406.62 Thousand USD | -2118.98% |
| 2023 FY | -1.3 Million USD | -235.98% |
| 2023 Q3 | 20.14 Thousand USD | -23.03% |
| 2023 Q2 | 26.16 Thousand USD | 11.58% |
| 2023 Q1 | 23.45 Thousand USD | -25.69% |
| 2022 Q2 | 291.25 Thousand USD | 5.03% |
| 2022 Q1 | 277.3 Thousand USD | 1106.05% |
| 2022 FY | 958.14 Thousand USD | 681.37% |
| 2022 Q4 | 31.55 Thousand USD | -91.19% |
| 2022 Q3 | 358.02 Thousand USD | 22.92% |
| 2021 Q3 | 46.66 Thousand USD | 128.81% |
| 2021 FY | 122.62 Thousand USD | -42.67% |
| 2021 Q4 | 22.99 Thousand USD | -50.73% |
| 2021 Q2 | 20.39 Thousand USD | -33.27% |
| 2021 Q1 | 30.56 Thousand USD | 57.81% |
| 2020 Q2 | 81.37 Thousand USD | -0.0% |
| 2020 FY | 213.87 Thousand USD | 2075.39% |
| 2020 Q4 | 19.36 Thousand USD | -39.01% |
| 2020 Q3 | 31.75 Thousand USD | -60.98% |
| 2020 Q1 | 81.37 Thousand USD | 0.0% |
| 2019 FY | -10.82 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 102.712% |
| Cerus Corporation | 86.4 Million USD | 99.902% |
| OrthoPediatrics Corp. | 111.25 Million USD | 99.924% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | 88.498% |
| Talis Biomedical Corporation | 371 Thousand USD | 77.073% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 98.972% |
| Inogen, Inc. | 126.69 Million USD | 99.933% |
| Spectral AI, Inc. | 7.88 Million USD | 98.921% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 101.29% |
| CVRx, Inc. | 33.03 Million USD | 99.743% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -39.443% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.983% |
| Venus Concept Inc. | 52.16 Million USD | 99.837% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 96.664% |
| Bioventus Inc. | 328.19 Million USD | 99.974% |
| BrainsWay Ltd. | 23.09 Million USD | 99.632% |
| Envoy Medical, Inc. | -473 Thousand USD | 117.983% |
| electroCore, Inc. | 13.22 Million USD | 99.357% |
| IceCure Medical Ltd | 1.3 Million USD | 93.457% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 101.406% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 279.694% |
| MaxCyte, Inc. | 36.54 Million USD | 99.767% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | 81.368% |
| PAVmed Inc | -3.96 Million USD | 102.144% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 101.551% |
| RxSight, Inc. | 53.76 Million USD | 99.842% |
| Sight Sciences, Inc. | 69.17 Million USD | 99.877% |
| SI-BONE, Inc. | 109.42 Million USD | 99.922% |
| TELA Bio, Inc. | 40.11 Million USD | 99.788% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 99.465% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 99.944% |
| LivaNova PLC | 771.25 Million USD | 99.989% |
| 908 Devices Inc. | 25.32 Million USD | 99.664% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.973% |
| Nemaura Medical Inc. | -1.47 Million USD | 105.761% |
| NeuroPace, Inc. | 48.12 Million USD | 99.823% |
| LENSAR, Inc. | 21.1 Million USD | 99.597% |
| Apyx Medical Corporation | 14.12 Million USD | 99.398% |
| Cutera, Inc. | 41.49 Million USD | 99.795% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 99.539% |
| BioSig Technologies, Inc. | 18 Thousand USD | -372.556% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 99.917% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 99.375% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.99% |
| Axonics, Inc. | 274.55 Million USD | 99.969% |
| Outset Medical, Inc. | 29 Million USD | 99.707% |
| IRIDEX Corporation | 21.8 Million USD | 99.61% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 99.88% |
| IRadimed Corporation | 50.15 Million USD | 99.83% |
| Tivic Health Systems, Inc. | 287 Thousand USD | 70.362% |
| INVO Bioscience, Inc. | 1.08 Million USD | 92.169% |
| Telesis Bio, Inc. | 16.95 Million USD | 99.498% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 99.925% |
| Varex Imaging Corporation | 256.9 Million USD | 99.967% |
| Quipt Home Medical Corp. | 163.84 Million USD | 99.948% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 120.951% |
| Pulmonx Corporation | 50.75 Million USD | 99.832% |
| Dynatronics Corporation | 7.63 Million USD | 98.886% |
| Modular Medical, Inc. | -768 Thousand USD | 111.076% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 98.467% |
| Semler Scientific, Inc. | 61.2 Million USD | 99.861% |
| InMode Ltd. | 411.34 Million USD | 99.979% |
| Bruker Corporation | 1.51 Billion USD | 99.994% |
| Cytosorbents Corporation | 22.39 Million USD | 99.62% |
| DexCom, Inc. | 2.28 Billion USD | 99.996% |
| Align Technology, Inc. | 2.71 Billion USD | 99.997% |
| Viveve Medical, Inc. | 620 Thousand USD | 86.281% |
| ZimVie Inc. | 290.38 Million USD | 99.971% |
| Movano Inc. | -158 Thousand USD | 153.835% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 99.922% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | 0.0% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.977% |
| Profound Medical Corp. | 4.51 Million USD | 98.116% |
| Insulet Corporation | 1.15 Billion USD | 99.993% |
| enVVeno Medical Corporation | -546 Thousand USD | 115.579% |
| Surmodics, Inc. | 93.05 Million USD | 99.909% |
| iCAD, Inc. | 14.53 Million USD | 99.415% |
| Nuwellis, Inc. | 4.98 Million USD | 98.293% |
| Biotricity, Inc. | 8.35 Million USD | 98.982% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.974% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 123.69% |
| InspireMD, Inc. | 1.8 Million USD | 95.293% |
| PAVmed Inc. | -3.96 Million USD | 102.144% |
| BIOLASE, Inc. | 16.72 Million USD | 99.491% |
| Beyond Air, Inc. | -1.3 Million USD | 106.508% |
| FONAR Corporation | 45.14 Million USD | 99.812% |
| AxoGen, Inc. | 127.87 Million USD | 99.933% |
| Vivani Medical, Inc. | -357 Thousand USD | 123.826% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.956% |
| Inari Medical, Inc. | 434.56 Million USD | 99.98% |
| UFP Technologies, Inc. | 112.22 Million USD | 99.924% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -579.447% |
| Tenon Medical, Inc. | 1.24 Million USD | 93.146% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 205.012% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 96.762% |
| AdaptHealth Corp. | 479.56 Million USD | 99.982% |
| Sintx Technologies, Inc. | 1.84 Million USD | 95.385% |
| NanoVibronix, Inc. | 1.53 Million USD | 94.466% |
| Quanterix Corporation | 70.64 Million USD | 99.88% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 120.951% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 99.395% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 99.839% |
| TransMedics Group, Inc. | 154.09 Million USD | 99.945% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 98.09% |
| NeuroMetrix, Inc. | 3.94 Million USD | 97.845% |
| Hyperfine, Inc. | 4.75 Million USD | 98.212% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 99.92% |
| Biomerica, Inc. | 611 Thousand USD | 86.079% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 99.796% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 110.892% |
| Silk Road Medical, Inc | 127.08 Million USD | 99.933% |